MedTrace Logo

Smoking, Stress & Allopregnanolone Response

NCT02087800 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2015-11-30

No results posted yet for this study

Summary

This study aims to characterize the effect of smoking on stress-induced allopregnanolone (ALLO) response in women by menstrual phase. The investigators hypothesize that women who smoke will have a blunted ALLO response to stress.

Conditions

  • Smoking Cessation

Interventions

BEHAVIORAL

F phase lab session

F phase sessions will occur three to seven days post the onset of menses. It will include blood draws, an acute stressor and completion of questionnaires.

BEHAVIORAL

L phase lab session

L phase sessions will occur six to ten days prior to the onset of the next expected menses. It will include blood draws, an acute stressor and completion of questionnaires.

Sponsors & Collaborators

Principal Investigators

  • Alicia Allen, PhD · University of Minnesota

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02087800 on ClinicalTrials.gov